Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis

Src kinase as a potential therapeutic target in non‐alcoholic and alcoholic steatohepatitis

Abstract Non‐alcoholic steatohepatitis (NASH) and alcohol‐associated steatohepatitis (ASH) are the major cause of liver‐related mortality with limited therapeutic options available. In this study, we investigated the role of Src tyrosine kinase in the pathogenesis of (N)ASH. We examined Src kinase e...

Full description

Bibliographic Details
Main Authors: Dhadhang Wahyu Kurniawan, Richell Booijink, Arun Kumar Jajoriya, Garima Dhawan, Divya Mishra, Dorenda Oosterhuis, Josepmaria Argemi, Gert Storm, Peter Olinga, Ramon Bataller, Sujit Kumar Mohanty, Durga Prasad Mishra, Jai Prakash, Ruchi Bansal
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Clinical and Translational Discovery
Subjects:
alcohol‐associated liver disease
fibrosis
inflammation
KX2‐391
non‐alcoholic fatty liver disease
steatosis
Online Access:https://doi.org/10.1002/ctd2.18

Internet

https://doi.org/10.1002/ctd2.18

Similar Items